NCT06584279View on ClinicalTrials.gov

Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer

RecruitingOBSERVATIONAL
Enrollment

563

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

April 30, 2025

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Biopsy of the prostate and pathological diagnosis

Whether the index-lesion-contralateral systematic biopsy was performed

Trial Locations (1)

Unknown

RECRUITING

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

All Listed Sponsors
lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER